Human Vaccine Research and Development, Manufacturer
Gelonghui, June 15 |WalvaxWalvax Biotechnology Co., Ltd. (300142.SZ) Announces Implementation of 2025 Annual Equity Distribution Plan: The Company’s 2025 annual equity distribution plan is to distribute a cash dividend of RMB 1.25 (tax inclusive) for every 10 shares to all shareholders, based on the total share capital of 1,599,348,541 shares after excluding 0 repurchased shares from the existing total share capital of 1,599,348,541 shares.
The record date for this equity distribution is June 23, 2026, and the ex-rights and ex-dividend date is June 24, 2026.